Introduction: Prostate magnetic resonance imaging (MRI) is now a key tool throughout the clinical care pathway for patients with prostate cancer, supporting detection, staging, treatment planning, and monitoring (1). Multiparametric MRI (mpMRI), combining morphologic T1W and T2W imaging, functional diffusion-weighted imaging (DWI), its derivative a

Introduction Two tasks are central to LGE-based clinical reporting:Cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement has fundamentally transformed the non-invasive assessment of myocardial disease. LGE-CMR enables direct visualisation of fibrosis and necrosis with a spatial resolution and histological correlation unachievabl

Tolebrutinib introduces a promising shift in the management of non-relapsing secondary progressive multiple sclerosis, a disease of the brain and spinal cord (1). By addressing smoldering neuroinflammation, it opens the door to earlier and more proactive intervention in disability progression.

Join Dr Lina Al Hamaty for the live webinar, “The Business Behind Clinical Practice.” This session explores the intersection of medical expertise and business strategy, focusing on healthcare innovation and the operational frameworks required for modern practice success. Speaker: Dr Lina Al Hamaty Healthcare Strategy and Business Development Consul

Introduction Radiotracers targeting the prostate-specific membrane antigen (PSMA) are widely used in clinical practice for positron emission tomography (PET) imaging of prostate cancer (1). PSMA is expressed as a type II transmembrane protein on the surface of prostate cancer cells, with moderate to low expression in healthy tissues and the highest

Introduction Prostate cancer (PCa) is the second most common cancer in men worldwide (1). Management of primary and recurrent PCa relies on accurate staging of the cancer through imaging and biopsyies (1). Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has become an increasingly established imagi

Women continue to shape healthcare through their contributions across clinical care, research, leadership, and community engagement. On International Women’s Day, in line with this year’s theme “Accelerate Action,” we invited women professionals from the healthcare community to share their perspectives. Their reflections explore two important quest

Artificial intelligence is now moving from pilot projects to becoming a core layer of how hospitals operate. This episode will focus on how AI agents are being used to streamline clinical workflows, optimise hospital resources, and support safer, faster decision-making across healthcare systems. Date: 19th January 2026 Time: 9:00 PM IST | 11:30 AM

Can doctors trust artificial intelligence? Join our upcoming webinar to explore how clinicians can shape, validate, and guide AI tools that are transforming modern medicine. Hear from: Mr. Bharat Gera — AI in Healthcare: The Human Voice — Expectations, Fears, and What Works Dr. Annie Hartley — Clinician-Led AI: How Doctors Should Validate and Trust